- Home
- TCRX vs BZFD Comparison
TCRX vs BZFD Comparison
Compare TCRX & BZFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- BZFD
- Stock Information
- Founded
- TCRX 2018
- BZFD 2006
- Country
- TCRX United States
- BZFD United States
- Employees
- TCRX N/A
- BZFD N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- BZFD Movies/Entertainment
- Sector
- TCRX Health Care
- BZFD Consumer Discretionary
- Exchange
- TCRX Nasdaq
- BZFD Nasdaq
- Market Cap
- TCRX 100.7M
- BZFD 82.8M
- IPO Year
- TCRX 2021
- BZFD N/A
- Fundamental
- Price
- TCRX $1.44
- BZFD $2.05
- Analyst Decision
- TCRX Strong Buy
- BZFD
- Analyst Count
- TCRX 6
- BZFD 0
- Target Price
- TCRX $9.50
- BZFD N/A
- AVG Volume (30 Days)
- TCRX 470.2K
- BZFD 311.9K
- Earning Date
- TCRX 08-11-2025
- BZFD 08-11-2025
- Dividend Yield
- TCRX N/A
- BZFD N/A
- EPS Growth
- TCRX N/A
- BZFD N/A
- EPS
- TCRX N/A
- BZFD 0.34
- Revenue
- TCRX $4,421,000.00
- BZFD $188,899,000.00
- Revenue This Year
- TCRX $159.20
- BZFD $6.29
- Revenue Next Year
- TCRX N/A
- BZFD $6.16
- P/E Ratio
- TCRX N/A
- BZFD $6.09
- Revenue Growth
- TCRX N/A
- BZFD N/A
- 52 Week Low
- TCRX $1.02
- BZFD $1.61
- 52 Week High
- TCRX $7.89
- BZFD $5.68
- Technical
- Relative Strength Index (RSI)
- TCRX 44.26
- BZFD 48.13
- Support Level
- TCRX $1.44
- BZFD $2.05
- Resistance Level
- TCRX $1.61
- BZFD $2.35
- Average True Range (ATR)
- TCRX 0.16
- BZFD 0.10
- MACD
- TCRX -0.02
- BZFD -0.02
- Stochastic Oscillator
- TCRX 10.44
- BZFD 3.33
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.